# Comparative Trial in Hormone Withdrawal Associated Symptoms

> **NCT01076582** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 592 (actual)

## Conditions studied

- Oral Contraceptive

## Interventions

- **DRUG:** EE20/DRSP (YAZ, BAY86-5300)
- **DRUG:** Ethinylestradiol (EE) and desogestrel (DSG) (Mercilon)

## Key facts

- **NCT ID:** NCT01076582
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 592 (ACTUAL)
- **Last updated:** 2014-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01076582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01076582, "Comparative Trial in Hormone Withdrawal Associated Symptoms". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01076582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*